119th Congress
H.R. 4752
Reducing Hereditary Cancer Act
- Introduced
- In committee
- Passed House
- Passed Senate
- To President
- Became law
- Sponsor
- Debbie Wasserman Schultz(D-FL)
- Introduced
- Jul 23, 2025
- Policy area
- Health
- Committees
- House Committee on Energy and Commerce; House Committee on Ways and Means
- Official text
- Introduced in House · Congress.gov page
Cosponsors (34)
Original cosponsors (3)
- Kim Schrier (D-WA)
- Mariannette Miller-Meeks (R-IA)
- Vern Buchanan (R-FL)
Added later (31)
- André Carson (D-IN) · Aug 8, 2025
- Debbie Dingell (D-MI) · Aug 8, 2025
- Josh Gottheimer (D-NJ) · Aug 8, 2025
- Lateefah Simon (D-CA) · Aug 8, 2025
- Steve Cohen (D-TN) · Aug 8, 2025
- Eleanor Holmes Norton (D-DC) · Aug 15, 2025
- Suzanne Bonamici (D-OR) · Aug 19, 2025
- Gilbert Ray Cisneros, Jr. (D-CA) · Oct 10, 2025
- Zachary Nunn (R-IA) · Nov 7, 2025
- Sarah McBride (D-DE) · Dec 9, 2025
- Brian K. Fitzpatrick (R-PA) · Feb 9, 2026
- Daniel S. Goldman (D-NY) · Feb 9, 2026
- Paul Tonko (D-NY) · Feb 9, 2026
- Timothy M. Kennedy (D-NY) · Feb 9, 2026
- Don Bacon (R-NE) · Feb 13, 2026
- Doris O. Matsui (D-CA) · Feb 13, 2026
- Jahana Hayes (D-CT) · Mar 19, 2026
- Madeleine Dean (D-PA) · Mar 19, 2026
- Burgess Owens (R-UT) · Apr 16, 2026
- Hillary J. Scholten (D-MI) · Apr 16, 2026
- Jennifer A. Kiggans (R-VA) · Apr 16, 2026
- Adelita S. Grijalva (D-AZ) · Apr 23, 2026
- Jonathan L. Jackson (D-IL) · Apr 23, 2026
- Shomari Figures (D-AL) · Apr 23, 2026
- Frederica S. Wilson (D-FL) · May 12, 2026
- Nicholas A. Langworthy (R-NY) · May 12, 2026
- Mark Pocan (D-WI) · Jun 18, 2026
- Nanette Diaz Barragán (D-CA) · Jun 18, 2026
- April McClain Delaney (D-MD) · Sep 2, 2026
- Yvette D. Clarke (D-NY) · Sep 28, 2026
- Chellie Pingree (D-ME) · Oct 9, 2026
Summary
Summary by the Congressional Research Service· describes the “Introduced in House” version
Reducing Hereditary Cancer Act
This bill provides for Medicare coverage of germline mutation testing for individuals with a personal or family history of a hereditary cancer gene mutation or suspected history of hereditary cancer, as well as for associated coverage of risk-reducing surgeries and screenings.
Roll-call votes
No recorded votes on this bill.
Actions
- Jul 23, 2025 · House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. - Jul 23, 2025
Introduced in House